XML 35 R22.htm IDEA: XBRL DOCUMENT
v3.8.0.1

SEGMENT AND GEOGRAPHIC INFORMATION | 12 Months Ended
--- | ---
Dec. 31, 2017
Segment Reporting [Abstract] |
SEGMENT AND GEOGRAPHIC INFORMATION | SEGMENT AND GEOGRAPHIC INFORMATION In the first quarter of 2015, the Company began to disclose three global reportable segments as a result of changes in how the Company internally manages and reports the results of its businesses to its chief operating decision maker. On July 1, 2015, the Company completed the separation of its spine business, which was a reportable segment. See Note 3 - Discontinued Operations for additional information. Following the separation, the Company is disclosing two reportable segments. In October 2017, as part of our branding strategy, the Company leveraged the globally recognized Codman name by rebranding the Specialty Surgical Solutions segment to Codman Specialty Surgical. The two reportable segments and their activities are described below:
• | The Codman Specialty Surgical segment includes (i) the Neurosurgery business, which sells a full line of products for neurosurgery and neuro critical care such as tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment and (ii) the precision tools and instruments business, which sells more than 60,000 instrument patterns and surgical and lighting products to hospitals, surgery centers, and dental, podiatry, and veterinary offices.
• | The Orthopedics and Tissue Technologies segment includes such offerings as skin and wound repair, bone and joint fixation implants in the upper and lower extremities, bone grafts and nerve and tendon repair.
The Corporate and other category includes (i) various legal, finance, information systems, executive, and human resource functions, (ii) brand management, and (iii) share-based compensation costs. Prior to the realignment, costs related to procurement, manufacturing operations and logistics for the Company's entire organization were not allocated to operating segments. In connection with the realignment, a portion of these costs have now been incorporated into the disclosed operating segments. The operating results of the various reportable segments as presented are not comparable to one another because (i) certain operating segments are more dependent than others on corporate functions for unallocated general and administrative and/or operational manufacturing functions, and (ii) the Company does not allocate certain manufacturing costs and general and administrative costs to the operating segment results. Net sales and profit by reportable segment for the years ended December 31, 2017, 2016 and 2015 are as follows:
| Years Ended December 31,
| 2017 |  | 2016 |  | 2015
| (In thousands)
Segment Net Sales |  |  |  |  |
Codman Specialty Surgical | $ | 720,301 |  |  | $ | 632,524 |  |  | $ | 586,918 |
Orthopedics and Tissue Technologies | 467,935 |  |  | 359,551 |  |  | 295,816 |
Total revenues | $ | 1,188,236 |  |  | $ | 992,075 |  |  | $ | 882,734 |
Segment Profit |  |  |  |  |
Codman Specialty Surgical | $ | 292,971 |  |  | $ | 256,629 |  |  | $ | 242,479 |
Orthopedics and Tissue Technologies | 129,697 |  |  | 103,852 |  |  | 87,844 |
Segment profit | 422,668 |  |  | 360,481 |  |  | 330,323 |
Amortization | (20,370) |  |  | (13,862) |  |  | (9,953) |
Corporate and other | (357,494 | ) |  | (231,279 | ) |  | (240,783 | )
Operating income | $ | 44,804 |  |  | $ | 115,340 |  |  | $ | 79,587 |
The Company does not allocate any assets to the reportable segments, and, therefore, no asset information is reported to the chief operating decision maker and disclosed in the financial information for each segment. The Company attributes revenue to geographic areas based on the location of the customer. There are certain revenues managed by the various U.S. segments above that are generated from non-U.S. customers and therefore included in Europe and the Rest of World revenues below. Total revenue, net and long-lived assets (tangible) by major geographic area are summarized below:
| United States* |  | Europe |  | Rest of the World |  | Consolidated
| (In thousands)
Total revenue, net: |  |  |  |  |  |  |
2017 | $ | 894,260 |  |  | $ | 150,147 |  |  | $ | 143,829 |  |  | $ | 1,188,236 |
2016 | 765,608 |  |  | 120,588 |  |  | 105,879 |  |  | 992,075 |
2015 | 680,824 |  |  | 103,057 |  |  | 98,853 |  |  | 882,734 |
Total long-lived assets: |  |  |  |  |  |  |
2017 | $ | 247,154 |  |  | $ | 30,942 |  |  | $ | 7,233 |  |  | $ | 285,329 |
2016 | 213,898 |  |  | 18,970 |  |  | 1,235 |  |  | 234,103 |
* Includes long-lived assets in Puerto Rico.

X
- References No definition available. + Details
Name: | us-gaap_SegmentReportingAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -URI http://asc.fasb.org/topic&trid=2134510 + Details
Name: | us-gaap_SegmentReportingDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration